David A. Conlon

Statistics

Publications

Citations

1.6K

H-Index

Active since

1983

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bristol-Myers Squibb (United States)

General Electric (United States)

David A. Conlon is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in chemistry, natural sciences, and organic chemistry.

ORCID

Publications per year

1983–2023

Publications

Mechanistic Aspects of Chiral Discrimination on Modified Cellulose

Thomas P. O’Brien, L. Crocker, Richard A. Thompson et al. · Analytical Chemistry · 1997 · 212 citations

Pharmacy, Biochemistry, Chemistry +17

Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir

Nicholas A. Meanwell, Mark Krystal, Beata Nowicka-Sans et al. · Journal of Medicinal Chemistry · 2017 · 140 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Suzuki–Miyaura Cross‐Coupling With Quasi‐Heterogeneous Palladium

David A. Conlon, Brenda Pipik, Simone Ferdinand et al. · Advanced Synthesis & Catalysis · 2003 · 131 citations

Natural Sciences, Chemical Engineering, Chemistry +5

Accelerating symmetry forbidden reactions: the vinylcyclopropane .fwdarw. cyclopentene cation radical rearrangement

Joseph P. Dinnocenzo, David A. Conlon · Journal of the American Chemical Society · 1988 · 76 citations

Natural Sciences, Chemistry, Chemical Kinetics +8

Aromatic bisvinyl ethers: A new class of highly reactive thermosetting monomers

James V. Crivello, David A. Conlon · Journal of Polymer Science Polymer Chemistry Edition · 1983 · 65 citations

Natural Sciences, Chemistry, Materials Science +14

1–5 of 45